LPA and coronary artery disorder: While numerous case-control studies dating back to the 1970s identified elevated Lp(a) (>30 mg/dl; >75 nmol/L) in coronary heart disease (CHD) patients, the contribution of Lp(a) to cardiovascular disease (CVD) risk remained unclear until many decades later.